Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
Clinical trial NCT00239356 · COMPLETED
Trial details
- NCT number
- NCT00239356
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.